THE LEBANESE ORDER OF PHARMACISTS 22nd PHARMACEUTICAL CONGRESS 24 ‐ 25 ‐ 26 October 2014 Hilton Habtoor Grand Hotel – Sin El Fil Friday 24 October 2014 Chairman and Moderator: Nadia Dalloul Ch i d M d t N di D ll l Topics in Pharmacy 10:00 ‐ 10:30 Use and Misuse of Antibiotics in Populations at Risk (Sanaa Awada) ‐ 0.5 CE 10:30 ‐ 11:00 Medication Considerations in the Pediatric Population (Randa Masri) ‐ 0.5 CE Coffee Break 11:00 ‐ 11:30 11:30 ‐ 12:00 Tadalafil 5mg Once Daily for the Treatment of Both ED and BPH‐LUTS (Pierre Sarkis) ‐ 0.5 CE 00 30 12:00 ‐ 12:30 y y ( ) Pharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient (Rania Lababidi) ‐ 0.5 CE 12:30 ‐ 13:00 La tuberculose: sujet d'actualité au Liban (Myrna Germanos) ‐ 0.5 CE Ch i Chairman and Moderator: Latife Karam d M d t L tif K Hospital and Clinical Practice 17:00 ‐ 17:30 Clinical and Hospital Pharmacy (Lama Al Hmoud) ‐ 0.5 CE 17:30 ‐ 17:45 Determination of Meropenem Stability over 8 hours in Solutions for IV infusion at Room Temperature and Quantitative/Stability Comparison of Marketed Brands (Omar Tabbouche) ‐ 0.25 CE 17:45 ‐ 18:00 Albumin Misuse And Abuse (Katia Iskandar) ‐ 0.25 CE Coffee Break 18:00 ‐ 18:30 18:30 ‐ 19:00 ( ) Clinical Scenarios in Parenteral Nutrition (Osama Tabbara) ‐ 0.5 CE 19:00 ‐ 19:30 Survey on Handling Chemotherapy Treatment in Hospitals (Wael Abi Ghanem ‐ Sandra Berberi) Saturday 25 October 2014 Saturday 25 October 2014 09:00 ‐ 11:00 Opening Ceremony 11:00 ‐ 11:30 Exhibition & Posters Inauguration 11:30 ‐ 12:00 11 30 12 00 Coffee Break Coffee Break 12:00 ‐ 14:00 Round Table: Medication Safety in the Arab World Moderator: Rouba El Rassi El Khoury Lunch Break Lunch Break 14 00 15 30 14:00 ‐ 15:30 Chairman: Faysal Abed Moderator: Dalal Hammoudi Chairman: Mohamed Rhaouti Moderator: Marianne Abi Fadel A Updates in Public Health B Career Development Indépendance/autonomie professionelle (Isabelle Adenot) Indépendance/autonomie professionelle (Isabelle Adenot) ‐ 0.5 CE Authentification securisée des professionels de santé (Patrick Fortuit) ‐ 0.5 CE Pharmacist, Ethics and Professional Autonomy (Ema Paulino) ‐ 0.5 CE Corona Virus Outbreak (Claude Afif) ‐ 0.5 CE 15:30 ‐ 17:00 Les enjeux du médicament vétérinaire (Aline Hajj) ‐ 0.5 CE Standard of Care Treatment Stage IV Colon Cancer (Fadi Karak) ‐ 0.5 CE Coffee Break / Poster Presentations 17:00 ‐ 17:30 17:30 ‐ 19:00 Chairman: Hayel Obeidat Moderator: Pascale Salameh Chairman: Mohamed Mahyoub Hassan Moderator: Yolande Saab A Safety Considerations Safety Considerations Application of Human Factors in Medication Safety (Rabih Dabliz) ‐ 0.5 CE Adverse Drug Events Associated with Vitamin K Antagonists: Factors of Therapeutic Imbalance (Amal El Hajje‐Nancy Helou) ‐ 0.5 CE B Management in Perspective Management in Perspective NICE Clinical Guideline on Medicines Adherence CG 76 (Mahendra Patel) ‐ 0.5 CE L Les complications toxiques des anticorps monoclonaux li ti t i d ti l utilisés en thérapeutique (Diane Antonios) ‐ 0.5 CE O Opportunities & Challenges in the Use of Pharmacy t iti & Ch ll i th U f Ph Technology (Osama Tabbara) ‐ 0.5 CE Emerging Hub for Pharmacoeconomics: The Jordanian Experience (Ibrahim Alabbadi) ‐ 0.5 CE Sunday 26 October 2014 09:30 ‐ 11:00 APSO Global Solution for Counterfeit Medicines (Room B) 11:00 ‐ 11:30 Coffee Break / Poster Presentations Chairman: Marc Antoine Zablith Moderator: Zeina Berjawi A Medical Laboratory Le syndrome métabolique (Salam Samad) ‐ 0.5 CE 11:30 ‐ 13:00 11:30 13:00 Surveillance biologique de la femme enceinte (Marie‐ Gabrielle Ghorra) ‐ 0.5 CE La résistance aux antibiotiques (Dolla Karam Sarkis) ‐ 0.5 CE Chairman: Ibrahim Alabbadi Moderator: Diana Charbel C Regulatory Affairs Good Storage and Distribution Practices (Christelle Françaoui) ‐ 0.5 CE JFDA in brief (Hayel Obeidat) ‐ 0.5 CE Chairman: Ahmad Eissa Moderator: Ahmad Yazibi B Counseling Corner I Iron in Infant Nutrition: What is the Evidence in 2014? i I f t N t iti Wh t i th E id i 2014? (Antoine Farah) ‐ 0.5 CE Stability of Pharmaceutical Products: Role of the Pharmacist (Mohamad Issa) ‐ 0.5 CE Pharmacist (Mohamad Issa) 0 5 CE Drugs and Nutrients Consideration after Bariatric Surgery (Marwan Akel) ‐ 0.5 CE (Marwan Akel) 0 5 CE UTI Treatment in Community Practice (Jihane Safwan) ‐ 0.5 CE Coffee Break Chairman: Ibrahim Al Joundi Moderator: Loma Machmouchi Chairman: Fares Al Chaar Moderator: Soha Sinno A Pharmaceutical Sciences B Metabolic Disorders: New Guidelines Updates in Diabetes: GLP1 Analogues and Insulin (Akram Echtay) ‐ 0.5 CE Updates on Hypertension Guidelines: “A Glance on the JNC 8” (Lama Soubra) ‐ 0.5 CE Cholesterol Management: State of the Art 2014 (Faraj Cholesterol Management: State of the Art 2014 (Faraj Saade) ‐ 0.5 CE La pharmacologie du placebo (Lydia Khabbaz) ‐ 0.5 CE 18:30 ‐ 19:30 Hyperhydrosis: The Silent Handicap (Hany Abi Ghosn) ‐ 0.5 CE A Updates in Pharmacy Practice Les prescriptions anti‐inflammatoires et anti‐infectieuses p p en dentisterie (Nada Farhat Mouchayleh‐Jeanine Gebeily) ‐ 0.5 CE Polycystic Ovary Syndrome Overview (Mona Nasrallah) ‐ 0.5 CE 16:00 ‐ 16:30 18:00 ‐ 18:30 Emollient Updates (Amal Mehanna) ‐ 0.5 CE Lunch Break Chairman: Abdelkarim Hamrouni Moderator: Nayla Sargi 16:30 ‐ 18:00 B Dermatology in Pharmacy Practice Regulatory Overview in KSA (Abdullah Almesned) ‐ 0.5 CE Hair Loss (Jasmin Abdelbaki) ‐ 0.5 CE 13:00 ‐ 14:30 14:30 ‐ 16:00 Chairman: Maryam Kaldari Moderator: Sabine Helou Hormesis: A Revolutionnary Approach to Pharmacology (Krikor Sahakian) ‐ 0.5 CE Dry Eyes More than just Reduced Tears! (Mohamed Dry Eyes… More than just Reduced Tears! (Mohamed Khalifeh) ‐ 0.5 CE Coffee Break Closing Ceremony ‐ General Discussion & Recall of Scientific Decision Together Towards a Brighter Future: OPL 2013‐2014 Updates (Rabih Hassouneh) Together Towards a Brighter Future: OPL 2013‐2014 Updates (Rabih Hassouneh)
© Copyright 2024 ExpyDoc